David A. Siegel Agenus Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $159,900 - $324,720	-123,000 Reduced 82.44%	26,200 $51,000
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $805,580 - $1.19 Million	-342,800 Reduced 69.67%	149,200 $367,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $780,516 - $1.53 Million	-267,300 Reduced 35.2%	492,000 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $3.19 Million - $4.24 Million	639,900 Added 535.93%	759,300 $3.99 Million
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $439,808 - $943,182	-171,800 Reduced 59.0%	119,400 $656,000
Q1 2021 May 17, 2021	SELL	$2.69 - $5.25 $1.19 Million - $2.33 Million	-443,500 Reduced 60.36%	291,200 $792,000
Q4 2020 Feb 16, 2021	SELL	$3.17 - $4.49 $11,095 - $15,715	-3,500 Reduced 0.47%	734,700 $2.34 Million
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $56,918 - $99,320	19,100 Added 2.66%	738,200 $2.95 Million
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $495,552 - $1.13 Million	258,100 Added 55.99%	719,100 $1.76 Million
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $842,295 - $1.54 Million	349,500 Added 313.45%	461,000 $1.88 Million
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $58,807 - $85,094	27,100 Added 32.11%	111,500 $288,000
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $121,692 - $146,224	48,100 Added 132.51%	84,400 $253,000
Q1 2019 May 15, 2019	BUY	$2.51 - $3.73 $45,681 - $67,886	18,200 Added 100.55%	36,300 $108,000
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $2,544 - $4,256	1,600 Added 9.7%	18,100 $43,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $72,663 - $110,594	-45,700 Reduced 73.47%	16,500 $35,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $89,721 - $184,605	39,700 Added 176.44%	62,200 $141,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $31,238 - $53,756	8,900 Added 65.44%	22,500 $106,000
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $44,336 - $65,008	13,600	13,600 $44,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account